These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6149758

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M, Kisfaludy S, Szalay F.
    Acta Physiol Hung; 1984; 64(3-4):455-60. PubMed ID: 6397971
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J, Deák G, Müzes G, Láng I, Niederland V, Nékám K, Kárteszi M.
    Orv Hetil; 1989 Dec 17; 130(51):2723-7. PubMed ID: 2574842
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gamma-glutamyltranspeptidase, aspartate aminotransferase, and erythrocyte mean corpuscular volume as indicators of alcohol consumption in liver disease.
    Eriksen J, Olsen PS, Thomsen AC.
    Scand J Gastroenterol; 1984 Sep 17; 19(6):813-9. PubMed ID: 6151242
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
    Pár A, Horváth T, Beró T, Kádas I, Pakodi F, Jávor T.
    Acta Physiol Hung; 1984 Sep 17; 64(3-4):449-54. PubMed ID: 6152369
    [Abstract] [Full Text] [Related]

  • 12. Treatment of alcohol-related liver disease with thioctic acid: a six month randomised double-blind trial.
    Marshall AW, Graul RS, Morgan MY, Sherlock S.
    Gut; 1982 Dec 17; 23(12):1088-93. PubMed ID: 6129179
    [Abstract] [Full Text] [Related]

  • 13. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ, Borg R.
    Minerva Dietol Gastroenterol; 1977 Dec 17; 23(3):237-42. PubMed ID: 372845
    [No Abstract] [Full Text] [Related]

  • 14. Utility of gamma-glutamyl transpeptidase and mean corpuscular volume in alcoholic liver disease.
    Baral N, Pokhrel S, Lamsal M, Yadav BN, Sah SP.
    Southeast Asian J Trop Med Public Health; 2005 Jul 17; 36(4):1007-10. PubMed ID: 16295559
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of chronic hepatitis. A comparative study of the effect azathioprine and (+)-cyanidanol-3].
    Aguilar Reina J, de la Santa López J, Cuadras Avellana CM, Kern A.
    Fortschr Med; 1978 Jan 12; 96(2):75-9. PubMed ID: 74352
    [Abstract] [Full Text] [Related]

  • 16. Long-term treatment of alcoholic liver disease with propylthiouracil.
    Orrego H, Blake JE, Blendis LM, Compton KV, Israel Y.
    N Engl J Med; 1987 Dec 03; 317(23):1421-7. PubMed ID: 3317042
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A, Paál M, Kádas I, Kerekes E, Jávor T.
    Acta Med Hung; 1983 Dec 03; 40(1):17-24. PubMed ID: 6664741
    [Abstract] [Full Text] [Related]

  • 19. [Study of therapy in chronic liver diseases. Double-blind study with cianidanol].
    Machalke K, Müller B.
    Fortschr Med; 1982 Apr 15; 100(14):665-7. PubMed ID: 6123478
    [No Abstract] [Full Text] [Related]

  • 20. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B, Schwarz M, Domke I, Grunert VP, Wuertemberger M, Schiemann U, Horster S, Limmer C, Stecker G, Soyka M.
    Addiction; 2005 Oct 15; 100(10):1477-86. PubMed ID: 16185209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.